“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart. View cart

Article: JAK2 inhibitor pacritinib significantly benefits patient reported outcomes in myelofibrosis

€3.03

SKU: product-article-18806 Category: General

Description

Description

JAK2 inhibitor pacritinib significantly benefits patient reported outcomes in myelofibrosis

Top

Article: JAK2 inhibitor pacritinib significantly benefits patient reported outcomes in myelofibrosis

Description

Related products

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in breast cancer

Article: Calendar of events

1 year subscription print edition of the Belgian Journal of Hematology (BJH)